Literature DB >> 22649147

Male reproductive health after childhood, adolescent, and young adult cancers: a report from the Children's Oncology Group.

Lisa B Kenney1, Laurie E Cohen, Margarett Shnorhavorian, Monika L Metzger, Barbara Lockart, Nobuko Hijiya, Eileen Duffey-Lind, Louis Constine, Daniel Green, Lillian Meacham.   

Abstract

The majority of children, adolescents, and young adults diagnosed with cancer will become long-term survivors. Although cancer therapy is associated with many adverse effects, one of the primary concerns of young male cancer survivors is reproductive health. Future fertility is often the focus of concern; however, it must be recognized that all aspects of male health, including pubertal development, testosterone production, and sexual function, can be impaired by cancer therapy. Although pretreatment strategies to preserve reproductive health have been beneficial to some male patients, many survivors remain at risk for long-term reproductive complications. Understanding risk factors and monitoring the reproductive health of young male survivors are important aspects of follow-up care. The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancer (COG-LTFU Guidelines) were created by the COG to provide recommendations for follow-up care of survivors at risk for long-term complications. The male health task force of the COG-LTFU Guidelines, composed of pediatric oncologists, endocrinologists, nurse practitioners, a urologist, and a radiation oncologist, is responsible for updating the COG-LTFU Guidelines every 2 years based on literature review and expert consensus. This review summarizes current task force recommendations for the assessment and management of male reproductive complications after treatment for childhood, adolescent, and young adult cancers. Issues related to male health that are being investigated, but currently not included in the COG-LTFU Guidelines, are also discussed. Ongoing investigation will inform future COG-LTFU Guideline recommendations for follow-up care to improve health and quality of life for male survivors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22649147      PMCID: PMC3438236          DOI: 10.1200/JCO.2011.38.6938

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  100 in total

Review 1.  Erectile dysfunction.

Authors:  T F Lue
Journal:  N Engl J Med       Date:  2000-06-15       Impact factor: 91.245

2.  Sperm morphology, motility, and concentration in fertile and infertile men.

Authors:  D S Guzick; J W Overstreet; P Factor-Litvak; C K Brazil; S T Nakajima; C Coutifaris; S A Carson; P Cisneros; M P Steinkampf; J A Hill; D Xu; D L Vogel
Journal:  N Engl J Med       Date:  2001-11-08       Impact factor: 91.245

3.  Postchemotherapy ejaculatory azoospermia: fatherhood with sperm from testis tissue with intracytoplasmic sperm injection.

Authors:  M N Damani; V Master; M V Meng; C Burgess; P Turek; R D Oates; V Masters
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

4.  Oncologists' attitudes and practices regarding banking sperm before cancer treatment.

Authors:  Leslie R Schover; Kimberly Brey; Alan Lichtin; Larry I Lipshultz; Sima Jeha
Journal:  J Clin Oncol       Date:  2002-04-01       Impact factor: 44.544

Review 5.  Disturbance of pubertal development after cancer treatment.

Authors:  Jørn Müller
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2002-03       Impact factor: 4.690

Review 6.  Male germ cell transplantation: an experimental approach with a clinical perspective.

Authors:  S Schlatt; V von Schönfeldt; A G Schepers
Journal:  Br Med Bull       Date:  2000       Impact factor: 4.291

7.  Intratesticular transplantation of testicular cells from leukemic rats causes transmission of leukemia.

Authors:  K Jahnukainen; M Hou; C Petersen; B Setchell; O Söder
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

8.  Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.

Authors:  S J Howell; J A Radford; J E Adams; E M Smets; R Warburton; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

9.  High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood.

Authors:  L B Kenney; M R Laufer; F D Grant; H Grier; L Diller
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

10.  Generation and in vitro differentiation of a spermatogonial cell line.

Authors:  Li-Xin Feng; Yali Chen; Luis Dettin; Renee A Reijo Pera; John C Herr; Erwin Goldberg; Martin Dym
Journal:  Science       Date:  2002-06-20       Impact factor: 47.728

View more
  33 in total

1.  Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.

Authors:  Wassim Chemaitilly; Qi Liu; Laura van Iersel; Kirsten K Ness; Zhenghong Li; Carmen L Wilson; Tara M Brinkman; James L Klosky; Nicole Barnes; Karen L Clark; Rebecca M Howell; Susan A Smith; Matthew J Krasin; Monika L Metzger; Gregory T Armstrong; Michael W Bishop; Hanneke M van Santen; Ching-Hon Pui; Deo Kumar Srivastava; Yutaka Yasui; Melissa M Hudson; Leslie L Robison; Daniel M Green; Charles A Sklar
Journal:  J Clin Oncol       Date:  2019-09-26       Impact factor: 44.544

2.  Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Authors:  Daniel M Green; Wei Liu; William H Kutteh; Raymond W Ke; Kyla C Shelton; Charles A Sklar; Wassim Chemaitilly; Ching-Hon Pui; James L Klosky; Sheri L Spunt; Monika L Metzger; DeoKumar Srivastava; Kirsten K Ness; Leslie L Robison; Melissa M Hudson
Journal:  Lancet Oncol       Date:  2014-09-16       Impact factor: 41.316

3.  Endocrine and Metabolic Disorders in Survivors of Childhood Cancers and Health-Related Quality of Life and Physical Activity.

Authors:  Kamnesh R Pradhan; Yan Chen; Sogol Moustoufi-Moab; Kevin Krull; Kevin C Oeffinger; Charles Sklar; Gregory T Armstrong; Kirsten K Ness; Leslie Robison; Yutaka Yasui; Paul C Nathan
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 4.  Testicular biopsy in prepubertal boys: a worthwhile minor surgical procedure?

Authors:  Alice Faure; Aurore Bouty; Mike O'Brien; Jorgen Thorup; John Hutson; Yves Heloury
Journal:  Nat Rev Urol       Date:  2016-01-20       Impact factor: 14.432

Review 5.  Iatrogenic genetic damage of spermatozoa.

Authors:  Cristian O'Flaherty
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

6.  Gonadal status in long-term male survivors of childhood cancer.

Authors:  E Brignardello; F Felicetti; A Castiglione; A Nervo; E Biasin; G Ciccone; F Fagioli; A Corrias
Journal:  J Cancer Res Clin Oncol       Date:  2016-02-10       Impact factor: 4.553

Review 7.  Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.

Authors:  H Irene Su; Yuton Tony Lee; Ronald Barr
Journal:  Cancer J       Date:  2018 Nov/Dec       Impact factor: 3.360

Review 8.  Reproductive health in the adolescent and young adult cancer patient: an innovative training program for oncology nurses.

Authors:  Susan T Vadaparampil; Nicole M Hutchins; Gwendolyn P Quinn
Journal:  J Cancer Educ       Date:  2013-03       Impact factor: 2.037

9.  Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.

Authors:  Eric J Chow; Kayla L Stratton; Wendy M Leisenring; Kevin C Oeffinger; Charles A Sklar; Sarah S Donaldson; Jill P Ginsberg; Lisa B Kenney; Jennifer M Levine; Leslie L Robison; Margarett Shnorhavorian; Marilyn Stovall; Gregory T Armstrong; Daniel M Green
Journal:  Lancet Oncol       Date:  2016-03-22       Impact factor: 41.316

Review 10.  Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.

Authors:  Eric J Chow; Lynnette Anderson; K Scott Baker; Smita Bhatia; Gregory M T Guilcher; Jennifer T Huang; Wendy Pelletier; Joanna L Perkins; Linda S Rivard; Tal Schechter; Ami J Shah; Karla D Wilson; Kenneth Wong; Satkiran S Grewal; Saro H Armenian; Lillian R Meacham; Daniel A Mulrooney; Sharon M Castellino
Journal:  Biol Blood Marrow Transplant       Date:  2016-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.